JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 18387645)

Published in Toxicol Appl Pharmacol on February 20, 2008

Authors

Jinhong Zhou1, Jian Ye, Xiaojia Zhao, Aiping Li, Jianwei Zhou

Author Affiliations

1: Department of Molecular Cell Biology and Toxicology, Institute of Toxicology, School of Public Health, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, People's Republic of China.

Articles citing this

TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer. Cell Death Dis (2014) 0.91

JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells. Cell Death Dis (2014) 0.89

Influence of toxicologically relevant metals on human epigenetic regulation. Toxicol Res (2015) 0.89

PRAF3 induces apoptosis and inhibits migration and invasion in human esophageal squamous cell carcinoma. BMC Cancer (2012) 0.85

Low dose and long term toxicity of sodium arsenite caused caspase dependent apoptosis based on morphology and biochemical character. Cell J (2012) 0.80

JWA gene regulates PANC-1 pancreatic cancer cell behaviors through MEK-ERK1/2 of the MAPK signaling pathway. Oncol Lett (2014) 0.78

EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells. Sci Rep (2015) 0.77

Identification of New Candidate Genes and Chemicals Related to Esophageal Cancer Using a Hybrid Interaction Network of Chemicals and Proteins. PLoS One (2015) 0.76

JWA regulates human esophageal squamous cell carcinoma and human esophageal cells through different mitogen-activated protein kinase signaling pathways. Exp Ther Med (2014) 0.75

MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1. Int J Biol Sci (2016) 0.75

JWA down-regulates HER2 expression via c-Cbl and induces lapatinib resistance in human gastric cancer cells. Oncotarget (2016) 0.75

JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells. Oncogenesis (2017) 0.75

Articles by these authors

Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2008) 21.36

Primer3--new capabilities and interfaces. Nucleic Acids Res (2012) 20.34

Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2009) 12.51

Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2010) 10.97

Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2011) 8.62

Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol (2010) 5.09

Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation (2010) 3.65

Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation (2007) 3.44

Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation (2006) 2.88

BLAST: a more efficient report with usability improvements. Nucleic Acids Res (2013) 2.77

Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation (2009) 2.00

Prevention and management of transcatheter balloon-expandable aortic valve malposition. Catheter Cardiovasc Interv (2008) 1.98

Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol (2009) 1.91

Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation (2012) 1.66

Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials. Clin Respir J (2014) 1.58

Comparison of visual performance after implantation of 3 types of intraocular lenses: accommodative, multifocal, and monofocal. Eur J Ophthalmol (2014) 1.57

Transatrial transcatheter tricuspid valve-in-valve implantation of balloon expandable bioprosthesis. Ann Thorac Surg (2010) 1.57

Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv (2009) 1.53

Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves. JACC Cardiovasc Interv (2012) 1.45

Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis. JACC Cardiovasc Interv (2010) 1.43

A modified protocol for retrograde cerebral perfusion: magnetic resonance spectroscopy in pigs. Eur J Cardiothorac Surg (2012) 1.40

A safe route to work? Accident experience of World Bank Group bike commuters. J Occup Environ Med (2009) 1.39

Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol (2012) 1.38

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer. J Immunol (2012) 1.38

Outcome of patients after transcatheter aortic valve embolization. JACC Cardiovasc Interv (2011) 1.37

A cell-intrinsic role for Mst1 in regulating thymocyte egress. J Immunol (2009) 1.35

Artificial microRNA-mediated virus resistance in plants. J Virol (2007) 1.28

Characterization of invasive Haemophilus influenzae disease in Manitoba, Canada, 2000-2006: invasive disease due to non-type b strains. Clin Infect Dis (2007) 1.23

Near-infrared dyes as contrast-enhancing agents for spectroscopic optical coherence tomography. Opt Lett (2004) 1.23

Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg (2009) 1.22

CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer. Gut (2012) 1.22

Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol (2012) 1.22

Technical considerations to avoid pitfalls during transapical aortic valve implantation. J Thorac Cardiovasc Surg (2010) 1.21

Aortic annulus diameter determination by multidetector computed tomography: reproducibility, applicability, and implications for transcatheter aortic valve implantation. JACC Cardiovasc Interv (2011) 1.20

5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol (2012) 1.18

Transapical transcatheter aortic valve implantation in the presence of a mitral prosthesis. J Am Coll Cardiol (2011) 1.17

Estrogenicity of organophosphorus and pyrethroid pesticides. J Toxicol Environ Health A (2002) 1.16

Association of EPHA2 polymorphisms and age-related cortical cataract in a Han Chinese population. Mol Vis (2011) 1.15

Atrioventricular block after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc Interv (2008) 1.11

Transcatheter valve-in-valve implantation for failed surgical bioprosthetic valves. J Am Coll Cardiol (2011) 1.09

Prognostic and predictive role of JWA and XRCC1 expressions in gastric cancer. Clin Cancer Res (2012) 1.09

Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines. EuroIntervention (2011) 1.07

Population genetics and antibiotic susceptibility of invasive Haemophilus influenzae in Manitoba, Canada, from 2000 to 2006. FEMS Immunol Med Microbiol (2007) 1.07

Effect of prosthesis-patient mismatch on long-term survival with aortic valve replacement: assessment to 15 years. Ann Thorac Surg (2010) 1.07

Multislice computed tomography for prediction of optimal angiographic deployment projections during transcatheter aortic valve implantation. JACC Cardiovasc Interv (2010) 1.06

Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer. Hum Pathol (2010) 1.06

Genetic variant in PSCA predicts survival of diffuse-type gastric cancer in a Chinese population. Int J Cancer (2010) 1.06

A functional polymorphism in Pre-miR-146a is associated with susceptibility to gastric cancer in a Chinese population. DNA Cell Biol (2012) 1.05

JWA regulates XRCC1 and functions as a novel base excision repair protein in oxidative-stress-induced DNA single-strand breaks. Nucleic Acids Res (2009) 1.05

A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population. Clin Cancer Res (2008) 1.03

JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton. Cell Signal (2007) 1.03

Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer. J Biomed Res (2012) 1.02

Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Catheter Cardiovasc Interv (2010) 1.01

Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation. J Am Coll Cardiol (2012) 1.00

Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-κB in arsenite-induced cell transformation. Free Radic Biol Med (2012) 0.99

Genetic variation in PLCE1 is associated with gastric cancer survival in a Chinese population. J Gastroenterol (2011) 0.99

Transapical transcatheter mitral valve-in-valve implantation in a human. Ann Thorac Surg (2009) 0.99

Common genetic variants in pre-microRNAs are associated with risk of coal workers' pneumoconiosis. J Hum Genet (2009) 0.99

Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications. Med Res Rev (2014) 0.98

Transcatheter transapical mitral valve-in-valve implantations for a failed bioprosthesis: a case series. J Thorac Cardiovasc Surg (2011) 0.96

The prognostic value of SOX2 expression in non-small cell lung cancer: a meta-analysis. PLoS One (2013) 0.96

Dissecting functions of KATANIN and WRINKLED1 in cotton fiber development by virus-induced gene silencing. Plant Physiol (2012) 0.96

Effects of optimism/pessimism and locus of control on disability and quality of life in Parkinson's disease. Parkinsonism Relat Disord (2009) 0.96

5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol (2013) 0.96

Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol (2012) 0.96

Dissecting the anti-desmoglein autoreactive B cell repertoire in pemphigus vulgaris patients. J Immunol (2007) 0.96

Level set based surface capturing in 3D medical images. Med Image Comput Comput Assist Interv (2008) 0.96

Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons. FASEB J (2006) 0.95

Associations of IL-4, IL-4R, and IL-13 gene polymorphisms in coal workers' pneumoconiosis in China: a case-control study. PLoS One (2011) 0.95

Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease. J Immunol (2014) 0.94

A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv (2011) 0.94

Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis. Pharmacogenet Genomics (2006) 0.94

Minority enrollment in Parkinson's disease clinical trials. Parkinsonism Relat Disord (2008) 0.93

Solution-processed DPP-based small molecule that gives high photovoltaic efficiency with judicious device optimization. ACS Appl Mater Interfaces (2013) 0.93

EMT and CSC-like properties mediated by the IKKβ/IκBα/RelA signal pathway via the transcriptional regulator, Snail, are involved in the arsenite-induced neoplastic transformation of human keratinocytes. Arch Toxicol (2012) 0.93

Early clinical outcomes after transapical aortic valve implantation: a propensity-matched comparison with conventional aortic valve replacement. J Thorac Cardiovasc Surg (2011) 0.93

Identification of JWA as a novel functional gene responsive to environmental oxidative stress induced by benzo[a]pyrene and hydrogen peroxide. Free Radic Biol Med (2007) 0.92

A new strain of Indian cassava mosaic virus causes a mosaic disease in the biodiesel crop Jatropha curcas. Arch Virol (2010) 0.92

A SNaPshot assay for genotyping 44 individual identification single nucleotide polymorphisms. Electrophoresis (2010) 0.92

A genetic variation in APE1 is associated with gastric cancer survival in a Chinese population. Cancer Sci (2011) 0.92

Can we trust the answers? Reliability and validity of self-reported sick leave due to musculoskeletal symptoms. J Occup Environ Med (2008) 0.92

JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer. Carcinogenesis (2013) 0.92

Ultralocal modification of surface plasmons properties in silver nanocubes. Nano Lett (2012) 0.91

The repressive effect of NF-kappaB on p53 by mot-2 is involved in human keratinocyte transformation induced by low levels of arsenite. Toxicol Sci (2010) 0.91

Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer. Cancer (2012) 0.91

Invasive potential of nonencapsulated disease isolates of Neisseria meningitidis. Infect Immun (2012) 0.91

Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells. Clin Exp Pharmacol Physiol (2005) 0.91

Isolation and identification of miRNAs in Jatropha curcas. Int J Biol Sci (2012) 0.90

JWA enhances As₂O₃-induced tubulin polymerization and apoptosis via p38 in HeLa and MCF-7 cells. Apoptosis (2011) 0.90

Effect of prosthesis-patient mismatch on long-term survival with mitral valve replacement: assessment to 15 years. Ann Thorac Surg (2009) 0.89